CClinicalTrials.gg
Status unknownNCT03788668Updated Feb 26, 2019

Role of Hyoid Suspension With Barbed Reposition Pharyngoplasty in Management of Lateral Pharyngeal Wall Collapse in Obstructive Sleep Apnea Patients

An interventional study of Hyoid suspension in Obstructive Sleep Apnea, sponsored by Assiut University. Status unknown at 1 site in Egypt. Open to participants aged 18 Years to 60 Years. Per ClinicalTrials.gov, last updated 2019-02-26.

Sponsored by Assiut University · Not applicable, Interventional, and Treatment

The sponsor has not verified this record recently (last verified Feb 2019), so the status shown — last known as Not yet recruiting — may be out of date.
Phase
Not applicable
Study type
Interventional
Enrollment
31
Allocation
Randomized
Ages
18 Years to 60 Years
Sex
All
01

Study summary

Aim of the study

To determine the exact role of hyoid bone suspension surgery in splinting lateral pharyngeal wall in the era of the lateral pharyngoplasty

Read the detailed description

Before recruitment of the patients, they will be subjected to detailed history taking and full ear nose throat examination. Body mass index and neck circumference will be measured. All the patients will undergo sleep study and the following parameters will be documented: Apnea hypopnea index (AHI), lowest O2 saturation index (LSO2), mean O2 saturation and percentage of sleep time with O2 saturation below 90% (CT90%). Day time sleepiness will be assessed using Epworth sleepiness score (ESS), we will use the Arabic translated version of ESS translated and validated after a multicentric study. All the patients will be examined by flexible fiber optic nasopharyngoscopy to determine the level of obstruction using Muller's maneuver. All the patients will be subjected to Drug Induced Sleep Endoscopy (DISE) to confirm the level of obstruction and the surgeon will comment on the lateral wall collapse at the level of oropharynx and hypopharynx. All the patients will be counseled about the other options of non-invasive treatment and importance of weight reduction. All the patients will sign an informed consent.

Surgical techniques:

The first step was bilateral tonsillectomy with identification and meticulous sparing of the palatoglossus and palatopharyngeus muscles; the most important trick was to spare as much as possible the mucosal covering of both anterior and posterior pillars. Two weakening or releasing partial incisions were done by a pinpoint bowie (Colorado) at the inferior (caudal) part of the palatopharyngeal muscle. A full thickness (mucosa and muscle) triangle was removed at the superolateral corner of the tonsil to obtain a wider and most squared oropharyngeal inlet. The center of the palate was marked at palatal spine also the pterygomandibular raphe in both sides were located by digital palpation and marked. We used a single barbed suture, bidirectional polydioxanone absorbable monofilament, size 0, with transition zone in the middle. One needle was introduced at the center point then passed laterally within the palate, turning around pterygomandibular raphe till it comes out at the most superior part of the raphe at one side; the thread is pulled until it hangs at the central transition zone which is a free zone present between the two directions of the thread. The needle again is re-introduced close to point of exit, passing around the pterygomandibular raphe, till it comes out into the tonsillectomy bed, then through the upper part of the palatopharyngeus muscle and comes out near to mucosa of posterior pillar not through it. The posterior pillar is entered at the junction between the upper third and the lower two-thirds. Then, again the needle is passed back through the tonsillectomy bed and then this suture will be suspended around the raphe again; a gentle traction is then applied on the thread only and no knots are taken. This leads to a stable re-positioning of the posterior pillar to more lateral and anterior location without any knot, then Marking the center of palate, pterygomandibular raphe and squaring of anterior pillars. The barbed suture around the upper part of the right raphe and it hangs at the central transition zone. c The needle is passed through the upper part of the palatopharyngeus muscle and comes out near to mucosa of posterior pillar not through it. The needle is passed through the upper pole and suspended around the raphe, pulling of barbed suture without taking of knots this stitch is repeated at least three times between raphe and muscle till the lower pole of the muscle is reached. The opposite side is done by the same way. Finally, each thread comes out at the raphe of the same side, for locking of the stitches and looseness prevention; a superficial stitch in the opposite direction is taken, and then the thread is cut while bushing the tissue downward for more traction.

Hyoid suspension (Thyro-hyoid-pexy) will be done. The hyoid suspension procedure will be performed under general anesthesia, with the patient in supine position with the neck extended. Skin marks over the mandibular margin, hyoid bone, thyroid notch and sternal notch. The skin incision followed a horizontal skin crease between the body of the hyoid bone and the thyroid notch. The incision will be carefully extended through the subcutaneous tissue and platysma muscle, as the muscle is less defined in the midline. Upper and lower subplatysmal flaps will be elevated to expose the strap muscles, which will be separated in the midline. The plane of the thyroid cartilage and the surface of the hyoid bone will be exposed and the thyrohyoid membrane was clearly defined. Vicryl 0 will be wrapped around the body of the hyoid bone on each side of the midline with a sharp needle and then directed to the thyroid lamina of the same side piercing it from the lateral to the medial surface, about ½ cm from the upper border of the cartilage. Two sutures will be performed on each side. The sutures will be tied steadily and gently,with the neck in neutral position. The wound will be closed in layers. A suction drainage will be placed for 48 hours.

Sample size:

In this prospective study, 31 patients will be included and will be randomized into two groups. Sample size calculation was done using sample size calculator software on ww.calculator.net website.

Randomization:

Patients will be randomized in two groups; Group (A) will undergo Barbed Reposition pharyngoplasty only and group (B) will under go Barbed Reposition pharyngoplasty and hyoid suspension. Simple randomization will be done by allowing the patients to choose between two sealed envelope.

Neither the pulmonologist or the phoniatricians or the surgeon who will perform post operative sleep study, post operative nasopharyngoscopy and post operative sleep endoscopy will know the type of operation performed to the patients.

Follow up:

Patients will be subjected to another sleep study, flexible fiber optic nasopharyngoscopy, drug induced sleep endoscopy and day time sleepiness evaluation using (ESS) 4 months after the surgery.

Statistical analysis:

The data will be tested for normality using the Kolmogorov-Smirnov test and for homogeneity variances prior to further statistical analysis. Chi-square and fisher exact tests will be used to compare between categorical variables. Unpaired t-test will be used to compare between continuous variables for normally distributed data and Mann Whitney U for non-normally distributed data. A two-tailed p \< 0.05 will be considered statistically significant. All analyses were performed with the International Business Machines Statistical Package for the Social Sciences International Business Machines 20.0 software.

02

Conditions studied

  • Obstructive Sleep Apnea

Keywords

  • Hyoid suspension
  • Barbed reposition pharyngoplasty
03

In context

Apnea

1,422 studies on the registry are indexed under Apnea; 159 are open to participants now.

This study's planned enrollment of 31 is below the median of 50 across 965 interventional studies indexed under Apnea.

Browse Apnea studies →

Lead sponsor

Assiut University is the lead sponsor of 4,901 studies on the registry; 2,098 are open to participants now.

Of its 13 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 60 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  1. Adult patients of both sexes between 18-60 years old.
  2. Moderate to severe obstructive sleep apnea diagnosed by sleep study with apnea hypopnea index (AHI) > 15/h.
  3. Body mass index (BMI) \<35.
  4. Refusing or intolerable to use continuous positive airway pressure.
  5. Lateral pharyngeal wall collapse diagnosed by drug induced sleep endoscopy.
  6. Patients who underwent previous tonsillectomy, adenoidectomy or previous nasal surgeries can be included.

Exclusion criteria

Exclusion Criteria:

  1. Patients who are unfit for surgeries.
  2. Patients who are tolerable to continuous positive airway pressure.
  3. Patients who underwent any palatal, pharyngeal, oral, mandibular, maxillofacial surgeries.
  4. Patients with central sleep apnea and neurological syndromes.
  5. Patients with neck, cervical vertebral pathologies and hypothyroidism.
  6. Patients who had facial skeletal abnormalities.
  7. Patients who had kissing tonsils or adenoids or huge tongue base.
  8. Patients who have other level of obstruction (beside oropharyngeal lateral wall collapse and hypopharyngeal retro lingual obstruction) will be excluded or have this level of obstruction completely managed before recruitment in the study.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Care provider, Investigator)
Enrollment
31 participants (estimated)

Study arms

  • Active comparator
    Hyoid suspension with barbed reposition pharyngoplasty

    Procedure: Hyoid suspension

  • No intervention
    barbed reposition pharyngoplasty

Interventions

  • ProcedureHyoid suspension

    Hyoid suspension will be done with barbed reposition pharyngoplasty

06

What researchers measure

Primary outcomes

  1. Apnea hypopnea index (AHI)

    Number of apneas and hypopneas recorded during sleep is an index used to indicate the severity of sleep apnea. It is represented by the number of apnea and hypopnea events per hour of sleep. The apneas (pauses in breathing) must last for at least 10 seconds and be associated with a decrease in blood oxygenation. Minimal: AHI \< 5 per hour Mild: AHI ≥ 5, but \< 15 per hour Moderate: AHI ≥ 15, but \< 30 per hour Severe: AHI ≥ 30 per hour decrease in the AHI indicate better outcome

    Time frame: 4 months after intervention

  2. lowest O2 saturation index (LSO2)

    Lowest 02 saturation during sleep Increase of this parameter indicate better outcome

    Time frame: 4 months after intervention

  3. mean O2 saturation

    Increase this parameter indicate better outcome

    Time frame: 4 months after intervention

  4. percentage of sleep time with O2 saturation below 90% (CT90%)

    Decrease in this parameter indicate better outcome

    Time frame: 4 months after intervention

  5. Degree of airway obstruction with Drug Induced Sleep Endoscopy (DISE)

    Degree of obstruction will be evaluated using grading system Grade 1 (0-25%) of airway is obstructed Grade 2 (25-50%) of airway obstructed Grade 3 (50-75%) of airway is obstructed Grade 4 (75-100%) of airway is obstructed Decrease in this parameter indicate better outcome

    Time frame: 4 months after intervention

Secondary outcomes

  1. Day time sleepiness will be assessed using Epworth sleepiness score (ESS)

    Decrease in this parameter indicate better outcome it is a questionnaire to assess the sleepniess during day time by assessment the chance of dozing during different daily activities it contain 8 question each one will be answered using a scale from 0-3 0= no dozing 1. slight chance of dozing 2. moderate chance of dozing 3. high chance of dozing Total score can range from 0-24 0-5 Lower Normal Daytime Sleepiness 6-10 Higher Normal Daytime Sleepiness 11-12 Mild Excessive Daytime Sleepiness 13-15 Moderate Excessive Daytime Sleepiness 16-24 Severe Excessive Daytime Sleepiness

    Time frame: 4 months after intervention

07

Study locations

1 site
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Feb 26, 2019, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03788668
Lead sponsor
Assiut University
Responsible party
Ahmed Ezzat Mohamed Saleh (Otorhinolaryngology Specialist, Assiut University) — Principal investigator
First posted
Dec 27, 2018
Start date
Apr 1, 2019 (estimated)
Primary completion
Dec 31, 2020 (estimated)
Completion
Jun 1, 2021 (estimated)
Last update
Feb 26, 2019

Study contacts

Ahmed Saleh, MSc
Contact
ahmed.saleh3@med.au.edu.eg
00201007178377
Ahmed Saleh, MSc
principal investigator · Otorhinolaryngology Specialist Assiut University Hospital

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Feb 2019. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion